6.5 CME + CE CREDITS

Accreditation Information

Pathology Visions covers a broad range of topics relevant to digital pathology. Digital pathology is growing rapidly as a method of viewing microscopic glass slides virtually. It encompasses the steps of scanning, interpretation, manipulation, analysis, distribution, and management. Digital images can be used for a wide variety of purposes, from education, evaluation, and research.

At Pathology Visions, the Digital Pathology Association offers workshops to bring attendees the most cutting-edge educational content and continuing medical education credits for those in attendance.

Conference Objectives

1. Understand the current state of technology and the recommended guidelines (by CAP and others) for using digital pathology in pathology practice.
2. Be familiar with the best practices of digital pathology in improving diagnostic accuracy, workflow, and cost reduction.
3. Understand the pitfalls and barriers to going digital and be familiar with available resources and networking opportunities in the digital pathology community to overcome these challenges.
4. Understand the opportunities for AI in digital pathology.
5. Be familiar with the practical financial, regulatory, and connectivity issues in digital pathology.
6. Knowing the utility and advantage of digital pathology and incorporating it in every aspect of pathology practice, including patient care, education, and research.
7. Knowing how to overcome barriers in implementation, regulation, and reimbursement.
8. Practicing digital pathology following the recommended guidelines for better patient care.

Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the College of American Pathologists (CAP) and the Digital Pathology Association. The College of American Pathologists is accredited by the ACCME to provide continuing medical education for physicians.

CME Designation

The CAP designates this live educational activity for a maximum of 6.5 AMA PRA Category 1 Credits ^TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

CE (Continuing Education for non-physicians)

The CAP designates this educational activity for a maximum of 6.5 credits of continuing education. Participants should claim only the credit commensurate with the extent of their participation in the activity.

This activity is approved for continuing education credit in the states of California and Florida.

The American Society for Clinical Pathology (ASCP) Board of Certification (BOC) Certification Maintenance Program (CMP) accepts this activity to meet the continuing education requirements.

Disclaimer

The content of this CME activity does not necessarily reflect the view or policies of the College of American Pathologists.

Disclosure Information

Below you will find the financial disclosure relationships for anyone who was able to affect the content of this educational activity.

The CAP mitigates all the relevant financial relationships listed for these individuals.

The following speakers/planners have no financial relationships with ACCME defined ineligible companies to disclose:

Planners: Po-Hao Chen, Chhavi Chauhan, Darshana Jhala, Nada Shaker, Mustafa Yousif

Faculty: Ibrahim Abukhiran, Usman Afzaal, Mohammad Alexanderani, Maria Amezquita, Wyatt Austin, Daljeet Bansal, Stephanie Blocker, Anne Buckley, Martin Burks, Yosep Chong, Isabela Cunha, Qiangqiang Gu, Lewis Hassell, Barry Huey, Alok Jadav, Tamara Jamaspishvili, Vi Le, Lucas Liu, Emilio Madrigal, Therry Malone, Liran Mao, Haider Mejbel, Jeremy Minkowitz, Muhammad Khalid Khan Niazi, Anil Parwani, Athittiyakorn Phonhong, Fattaneh Pourakpour, Ehsan Ullah, Michael Valante, Tianyang Wang, Michelle Wood-Trageser, Nasim Yahyasoltani, Hanying Yan, George Yousef

The following speakers/planners have the following financial relationships to disclose:

Sylvia Asa, Advisory board Member relationship with Boehringer-Ingelheim; Advisory Board Member relationship with Leica Biosystems

Riyue Bao, PhD, Inventor on IP relationship with University of Chicago

Marilyn Bui, MD, PhD, Advisory board member relationship with DigitCells; Consultant relationship with AbbVie; Yes; Advisory board member relationship with PathAI; Consultant relationship with AstraZeneca; Advisory board member relationship with Aiforia; Advisory board member relationship with Vasiopharm

Matthew Cecchini, MD PhD, London Health Sciences Centre, Author, Consultant relationship with Tenomix; Speaker relationship with Eli Lilly; Consultant relationship with Need; speaker relationship with Astra Zeneca; speaker relationship with Merck; speaker relationship with Amgen; undefined; speaker relationship with Pfizer

Matthew Hanna, MD, Advisory board member relationship with Danaher; Speaker bureau relationship with Hologic; Advisory board member relationship with AstraZeneca; Advisory board member relationship with Roche; Advisory board member relationship with Johnson & Johnson

Syed T. Hoda, Consultant relationship with Health Advances

Emilio Madrigal, DO,  Independent contractor relationship with Hologic; Independent contractor relationship with AstraZeneca

Saad Nadeem, PhD,  Speaker bureau relationship with Roche Tissue Diagnostics; AI Distribution relationship with PathPresenter

Juan Santa-Rosario, MD, Consultant relationship with Techcyte; Consultant relationship with Ibex Medical Analytics

Swati Satturwar, MD, Consultant relationship with AIXMed

Joshua Swamidass, MD PhD, Founder relationship with Trusted Kidney

Maureen Waithaka, MBChB, MMed, panelist at Oncology Summit relationship with AstraZeneca (Kenya);  Advisory board Member relationship with AstraZeneca

No in-kind support or commercial support has been received for this activity.